
2.10 Delayed Data As of May 20 | ![]() Today’s Change | 1.67 Today|||52-Week Range 5.06 | -37.87% Year-to-Date |
The 8 analysts offering 12-month price forecasts for Cymabay Therapeutics Inc have a median target of 10.00, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +376.19% increase from the last price of 2.10.
The current consensus among 8 polled investment analysts is to Buy stock in Cymabay Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.